Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.32 |
| ▸ | PRNP | P04156 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20175516 | 0.92 | ALOX5 (0.40) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL20175486 | 0.91 | ATM (0.42) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL20175600 | 0.90 | ATM (0.41) | ATMKDM4EL3MBTL1DUSP3HSD17B10 | |
| SCHEMBL20175512 | 0.87 | ATM (0.40) | ATMKDM4EL3MBTL1DUSP3HSD17B10 | |
| SCHEMBL21709256 | 0.86 | KDM4E (0.38) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL14725762 | 0.84 | L3MBTL1 (0.37) | ATMKDM4EL3MBTL1DUSP3HSD17B10 | |
| SCHEMBL21942167 | 0.83 | KDM4E (0.35) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL20175487 | 0.83 | ATM (0.42) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL20175465 | 0.83 | ATM (0.42) | ATMKDM4EL3MBTL1HSD17B10MAPT | |
| SCHEMBL20706875 | 0.83 | ATM (0.46) | ATMKDM4EL3MBTL1DUSP3HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10717744-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-07-21 | — | — | US | disclosed |
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | ATM 4361/4885KDM4E 1121/4885L3MBTL1 561/4885 |
| US-10717744-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, LEF1 | ATM 4361/4885KDM4E 1121/4885L3MBTL1 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.